RARE - Ultragenyx Pharmaceutical GAAP EPS of -$2.23 misses by $0.12 revenue of $98.1M misses by $4.78M
2023-11-02 17:01:04 ET
More on Ultragenyx Pharmaceutical
- Ultragenyx: Market Expectations Revised Lower, Awaiting Clinical Trial Catalysts (Rating Downgrade)
- Ultragenyx Pharmaceutical prices $300 million securities offering
- Seeking Alpha’s Quant Rating on Ultragenyx Pharmaceutical
- Historical earnings data for Ultragenyx Pharmaceutical
- Financial information for Ultragenyx Pharmaceutical
For further details see:
Ultragenyx Pharmaceutical GAAP EPS of -$2.23 misses by $0.12, revenue of $98.1M misses by $4.78M